Table 1.
β-Actin | α-Actin | |||
---|---|---|---|---|
PTM | Endogenous | Recombinant | Endogenous | Recombinant |
Nt-acetylation | 100 (61/61) | 98 (96/98) | 99 (200/203) | 100 (258/259) |
K18 acetylation | 11 (7/61) | 11 (11/98) | 5 (10/203) | |
K50 acetylation | 7 (16/217) | 7 (16/231) | 12 (42/337) | 15 (53/353) |
K61 methylation | 6 (8/134) | 8 (12/146) | 5 (11/214) | |
K68 acetylation | 19 (10/52) | 16 (8/49) | 17 (9/54) | 9 (4/46) |
H73 methylation | 94 (246/263) | 93 (286/308) | 96 (412/430) | 92 (314/341) |
K84 acetylation | 11 (40/361) | |||
H101 methylation | 10 (25/240) | 10 (26/264) | 6 (19/300) | 5 (16/336) |
K113 acetylation | 5 (16/300) | 5 (16/336) | ||
H161 methylation | 15 (57/372) | 17 (68/410) | 7 (33/501) | |
K191 acetylation | 9 (21/224) | 11 (31/284) | 15 (74/493) | 18 (125/706) |
K213 acetylation | 17 (5/30) | 8 (5/65) | 12 (18/146) | |
K215 acetylation | 13 (6/47) | 13 (7/52) | 20 (24/119) | 8 (14/176) |
K215 methylation | 13 (6/47) | 12 (6/52) | 5 (6/119) | 5 (8/176) |
Y218 phosphorylation | 18 (32/179) | 11 (22/201) | ||
R256 methylation | 7 (1/15) | 8 (2/24) | 7 (16/242) | 6 (29/451) |
H275 methylation | 28 (13/47) | 32 (26/82) | 8 (52/664) | 5 (45/965) |
K284 acetylation | 14 (8/59) | 13 (11/82) | 11 (46/419) | 15 (63/420) |
K284 methylation | 14 (8/59) | 9 (7/82) | ||
K291 acetylation | 17 (46/268) | 20 (60/298) | 21 (75/358) | 21 (85/400) |
K315 acetylation | 7 (1/14) | 30 (3/10) | ||
K315 methylation | 25 (1/4) | 21 (3/14) | ||
K328 acetylation | 20 (2/10) | 35 (6/17) | 64 (14/22) | 40 (6/15) |
K328 methylation | 20 (2/10) | 12 (2/17) | ||
H371 methylation | 5 (5/110) |
For each PTM, the percentile occupancy is defined as 100 × the ratio of the number of peptides containing the PTM to the total number of observed peptides (shown in parentheses). See also Fig. 4 and SI Appendix, Figs. S3 and S4.